Earnings
BHVN
79.67
+2.35%
1.83
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
316.73M
--
--
--
--
--
2.98M
--
--
--
8.57M
4000.00
328.28M
8.15M
--
5.34M
--
--
--
--
2.49M
15.98M
344.26M
--
14.07M
0.00
--
--
--
--
--
52.10M
--
--
--
--
66.17M
247.76M
--
--
--
37.76M
285.51M
351.69M
881.43M
83.52M
-972.37M
--
--
--
-7.42M
-7.42M
344.26M
FY 2018-12-31
264.25M
--
--
--
--
--
0.00
--
--
--
7.60M
487.00K
272.34M
6.25M
--
11.41M
--
--
--
--
11.00K
17.67M
290.01M
--
10.75M
0.00
--
--
--
--
--
8.78M
--
--
--
--
19.53M
117.52M
--
--
--
2.04M
119.56M
139.09M
554.38M
40.10M
-443.57M
--
--
--
150.92M
150.92M
290.01M
FY 2017-12-31
131.47M
--
--
--
--
--
0.00
--
--
--
5.10M
100.00K
136.66M
2.34M
--
7.85M
--
--
--
--
32.00K
10.22M
146.89M
--
4.72M
0.00
--
--
--
--
--
4.71M
--
--
--
--
9.43M
0.00
--
--
--
5.49M
5.49M
14.92M
311.06M
23.56M
-202.65M
--
--
--
131.97M
131.97M
146.89M
FY 2016-12-31
23.57M
--
--
--
--
--
0.00
--
--
--
388.00K
82.00K
24.04M
26.00K
--
2.75M
--
--
--
--
203.00K
2.98M
27.02M
--
746.00K
4.22M
--
--
--
--
--
2.88M
--
--
--
99.00K
7.94M
20.31M
--
--
--
525.00K
20.84M
28.78M
19.94M
10.48M
-75.46M
--
--
0.00
-1.76M
-1.76M
27.02M
FY 2015-12-31
1.46M
--
--
--
--
--
0.00
--
--
--
387.00K
40.00K
1.89M
5000.00
--
0.00
--
--
--
--
0.00
5000.00
1.89M
--
68.00K
0.00
--
--
--
--
--
179.00K
--
--
--
82.00K
329.00K
0.00
--
--
--
476.00K
419.00K
805.00K
8.66M
4.26M
-11.78M
--
--
-57.00K
1.14M
1.09M
1.89M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out BHVN latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Biohaven Pharma recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.